UTI Healthcare Fund - Regular Plan - Growth Option
💡 Why Pick This Fund? Quantitative Strengths & Watch-outs
- Outperformed category benchmark in 64% of historical 3-year rolling periods.
- Strong capital defense: downside capture of 57% limits losses during market corrections.
- Generated +11.6% annualized alpha (excess return) over its benchmark.
- Cost-efficient: expense ratio of 2.2% is lower than category median (2.52%).
- Equities carry market risk; returns fluctuate and recommended investment horizon is 5+ years.
Key Statistics vs Category Median
Trailing Returns Comparison
| Period | Fund Return | Category Median | Difference |
|---|---|---|---|
| 1 Month | +7.84% | +6.32% | +1.52% |
| 3 Months | +2.25% | -0.20% | +2.45% |
| 6 Months | +15.05% | +5.98% | +9.07% |
| 1 Year | +21.47% | +3.90% | +17.57% |
| 3 Years CAGR | +22.74% | +13.23% | +9.51% |
| 5 Years CAGR | +16.48% | +10.72% | +5.76% |
| 7 Years CAGR | +23.25% | +15.35% | +7.90% |
| 10 Years CAGR | +14.60% | +14.26% | +0.34% |
| Since Inception | +13.84% | - | - |
📈 Monthly SIP vs Bank Fixed Deposit (FD) Replay
See how a regular monthly SIP in UTI Healthcare Fund compares against a standard 7.0% p.a. Bank Fixed Deposit.
Calendar Year Returns
| Year | Fund | Category Median | Gap |
|---|---|---|---|
| 2026 | +23.54% | +4.03% | +19.51% |
| 2025 | -3.15% | +1.43% | -4.58% |
| 2024 | +42.86% | +20.41% | +22.45% |
| 2023 | +38.20% | +30.70% | +7.50% |
| 2022 | -12.32% | +1.66% | -13.98% |
| 2021 | +19.08% | +30.31% | -11.23% |
| 2020 | +67.36% | +13.54% | +53.82% |
| 2019 | +1.18% | +7.11% | -5.93% |
| 2018 | -7.53% | -5.94% | -1.59% |
| 2017 | +6.20% | +39.22% | -33.02% |
| 2016 | -9.71% | +4.10% | -13.81% |
| 2015 | +12.37% | +1.85% | +10.52% |
| 2014 | +43.74% | +52.06% | -8.32% |
| 2013 | +23.26% | -4.06% | +27.32% |
| 2012 | +24.78% | +26.60% | -1.82% |
| 2011 | -9.56% | -23.05% | +13.49% |
| 2010 | +37.37% | +18.91% | +18.46% |
| 2009 | +66.70% | +77.75% | -11.05% |
| 2008 | -25.95% | -57.13% | +31.18% |
| 2007 | +12.08% | +66.75% | -54.67% |
Daily Rolling Returns Summary
| Rolling Window | Minimum | Average | Median | Maximum | % Positive | % Beating Proxy |
|---|---|---|---|---|---|---|
| 1-Year Rolling | -27.19% | +17.04% | +12.16% | +99.77% | 69.0% | 56.4% |
| 3-Year Rolling | -9.55% | +16.10% | +17.71% | +38.00% | 87.7% | 64.5% |
| 5-Year Rolling | -5.72% | +15.16% | +14.76% | +30.98% | 97.5% | 62.2% |
Risk Profile & Deepest Drawdowns
Deepest Market Corrections (Depth >= 10%)
| Peak Date | Trough Date | Fall Depth | Months to Bottom | Recovery Period |
|---|---|---|---|---|
| 2008-01-02 | 2009-03-03 | -33.9% | 14 months | 7 months |
| 2006-05-10 | 2006-06-14 | -32.6% | 1 months | 19 months |
| 2015-04-08 | 2020-03-23 | -30.5% | 59 months | 3 months |
Portfolio & Asset Allocation
Statutory Asset Allocation Mandate (SEBI / SID)
| Instrument Category | Permitted Allocation Range |
|---|---|
| Equity and equity related instruments of entities related to the healthcare services sector | 80% - 100% Money Market Instruments and other instruments permissible under residual portion: 0% - 20% |
Investment Objective & Strategy
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.
Fund Size Position
Currently managing Rs 1,536 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as comfortable relative to Sectoral / Thematic schemes.
Fund Management
Cost & Capital Gains Taxation
From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.
Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.
Closest Sectoral / Thematic Peers by Rank
| Scheme | Score | 3Y Return | Expense | Downside | Fund Size | Compare |
|---|---|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND | 7.2 | +23.97% | 1.98% | 43.4% | Rs 6,504 cr | Compare → |
| Mirae Asset Healthcare Fund | 7.9 | +22.67% | - | 45.7% | Rs 3,828 cr | Compare → |
| Nippon India Taiwan Equity fund | 7.2 | +45.47% | 2.39% | -77.2% | Rs 806 cr | Compare → |
| DSP Healthcare Fund | 8.0 | +20.31% | 2.04% | 53.2% | Rs 3,946 cr | Compare → |
| Aditya Birla Sun Life International Equity Fund | 5.8 | +20.53% | 2.55% | -28.3% | Rs 337 cr | Compare → |
Frequently Asked Questions about UTI Healthcare Fund
What is the expense ratio of UTI Healthcare Fund?
UTI Healthcare Fund has a total expense ratio (TER) of 2.2% with a base expense ratio of 1.81%, compared to the Sectoral / Thematic category median of 2.52%.
Who manages UTI Healthcare Fund?
UTI Healthcare Fund is managed by Kamal Gada (tenure: 4.5 years since 2022-05-02).
What are the historical returns of UTI Healthcare Fund?
UTI Healthcare Fund delivered a 3-year CAGR of 22.74% and a 5-year CAGR of 16.48%. Its 1-year return stands at +21.47%.
How large is UTI Healthcare Fund?
UTI Healthcare Fund manages assets of Rs 1,536 cr, placing it in the 'comfortable' size band relative to Sectoral / Thematic peers.
How is UTI Healthcare Fund scored on MFIQ?
UTI Healthcare Fund holds an MFIQ Score of 7.0/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.
How risky is UTI Healthcare Fund?
UTI Healthcare Fund has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.67% with a maximum historical drawdown of -33.91%.